Società Brainstorm Cell Therapeutics Inc OTC Bulletin Board
Azioni
US10501E1029
Biotecnologia
Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/12 |
Chief Tech/Sci/R&D Officer | - | 12/05/22 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/07/23 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/07 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
General Counsel | - | 12/05/22 | |
Mary Kay Turner
LAW | General Counsel | - | 07/08/17 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/09/00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
Jacob Frenkel
CHM | Chairman | 81 | 30/03/20 |
Director/Board Member | 63 | 28/10/21 | |
Director/Board Member | 61 | 05/02/18 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Nir Naor
BRD | Director/Board Member | 50 | 20/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 68 341 857 | 59 269 308 ( 86,72 %) | 0 | 86,72 % |
Coordinate società
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+17,96% | 44,96 Mrd | |
+1,17% | 42,65 Mrd | |
+48,77% | 41,85 Mrd | |
-4,27% | 29,04 Mrd | |
+11,42% | 26,08 Mrd | |
-21,39% | 19,03 Mrd | |
+4,86% | 12,75 Mrd | |
+27,29% | 12,06 Mrd | |
-3,50% | 11,75 Mrd |
- Borsa valori
- Azioni
- Azione BCLI
- Azione
- Società Brainstorm Cell Therapeutics Inc